Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319915651> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4319915651 endingPage "456a" @default.
- W4319915651 startingPage "455a" @default.
- W4319915651 abstract "Extracellular vesicles (EVs) have gained widespread interest due to their potential in the treatment of inflammation, autoimmune diseases, and immuno-cancer therapy. Among various classes of EVs such as microvesicles (MVs), exosomes, and apoptotic bodies, exosomes are of endosomal origin that are released into the extracellular environment. Exosomes carry complex sets of cargo from their cells of origin, including proteins, lipids, mRNA, and DNA, hence exhibit “Mother Nature”. These are typically 30-150 nm lipidic vesicles rich in integrin proteins that facilitate intrinsic cellular targeting. Within the background, we hypothesized that when these exosomes are hybridized with synthetic liposomes, it would help navigate the hybrid construct in the complex biological environment to find its target. Toward this endeavor, we have re-engineered a synthetic liposome with the exosomes (herein called LEVs) derived from mouse breast cancer and incorporated a fluorescent dye to investigate its potential for cellular targeting. Using the membrane extrusion, we have successfully hybridized both entities resulting in the formation of LEVs and characterized for their colloidal properties and stability over a period. LEVs were monodispersed with an average hydrodynamic size of 120±6. Using Elisa and western-blot, we monitored and quantified exosome-specific protein CD63, which was taken as a handle to ensure the reproducibility of exosome and LEVs. These LEVs were rapidly taken up by immune cells and their parent cells thereby confirming their targeting properties, which can be exploited in drug delivery applications. We will discuss biomedical applications such as its distribution in an animal model, biocompatibility, and imaging in this presentation. We anticipate that this study can picture future opportunities for drug delivery solutions that are superior in target recognition." @default.
- W4319915651 created "2023-02-11" @default.
- W4319915651 creator A5025865445 @default.
- W4319915651 creator A5050797480 @default.
- W4319915651 date "2023-02-01" @default.
- W4319915651 modified "2023-09-25" @default.
- W4319915651 title "Tumor-derived extracellular vesicles hybridized liposomes in cancer therapy" @default.
- W4319915651 doi "https://doi.org/10.1016/j.bpj.2022.11.2450" @default.
- W4319915651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36784335" @default.
- W4319915651 hasPublicationYear "2023" @default.
- W4319915651 type Work @default.
- W4319915651 citedByCount "0" @default.
- W4319915651 crossrefType "journal-article" @default.
- W4319915651 hasAuthorship W4319915651A5025865445 @default.
- W4319915651 hasAuthorship W4319915651A5050797480 @default.
- W4319915651 hasConcept C121608353 @default.
- W4319915651 hasConcept C12554922 @default.
- W4319915651 hasConcept C126322002 @default.
- W4319915651 hasConcept C130316041 @default.
- W4319915651 hasConcept C185154212 @default.
- W4319915651 hasConcept C185592680 @default.
- W4319915651 hasConcept C28406088 @default.
- W4319915651 hasConcept C2983331546 @default.
- W4319915651 hasConcept C2992929900 @default.
- W4319915651 hasConcept C41625074 @default.
- W4319915651 hasConcept C55493867 @default.
- W4319915651 hasConcept C71924100 @default.
- W4319915651 hasConcept C86803240 @default.
- W4319915651 hasConcept C95444343 @default.
- W4319915651 hasConceptScore W4319915651C121608353 @default.
- W4319915651 hasConceptScore W4319915651C12554922 @default.
- W4319915651 hasConceptScore W4319915651C126322002 @default.
- W4319915651 hasConceptScore W4319915651C130316041 @default.
- W4319915651 hasConceptScore W4319915651C185154212 @default.
- W4319915651 hasConceptScore W4319915651C185592680 @default.
- W4319915651 hasConceptScore W4319915651C28406088 @default.
- W4319915651 hasConceptScore W4319915651C2983331546 @default.
- W4319915651 hasConceptScore W4319915651C2992929900 @default.
- W4319915651 hasConceptScore W4319915651C41625074 @default.
- W4319915651 hasConceptScore W4319915651C55493867 @default.
- W4319915651 hasConceptScore W4319915651C71924100 @default.
- W4319915651 hasConceptScore W4319915651C86803240 @default.
- W4319915651 hasConceptScore W4319915651C95444343 @default.
- W4319915651 hasIssue "3" @default.
- W4319915651 hasLocation W43199156511 @default.
- W4319915651 hasLocation W43199156512 @default.
- W4319915651 hasOpenAccess W4319915651 @default.
- W4319915651 hasPrimaryLocation W43199156511 @default.
- W4319915651 hasRelatedWork W2008732666 @default.
- W4319915651 hasRelatedWork W2045308798 @default.
- W4319915651 hasRelatedWork W2061604571 @default.
- W4319915651 hasRelatedWork W2089532729 @default.
- W4319915651 hasRelatedWork W2780439829 @default.
- W4319915651 hasRelatedWork W2808976093 @default.
- W4319915651 hasRelatedWork W2905073085 @default.
- W4319915651 hasRelatedWork W3010618187 @default.
- W4319915651 hasRelatedWork W4244822608 @default.
- W4319915651 hasRelatedWork W4311505397 @default.
- W4319915651 hasVolume "122" @default.
- W4319915651 isParatext "false" @default.
- W4319915651 isRetracted "false" @default.
- W4319915651 workType "article" @default.